Statin Twitter: Human and Automated Bot Contributions, 2010 to 2022
Background Many individuals eligible for statin therapy decline treatment, often due to fear of adverse effects. Misinformation about statins is common and drives statin reluctance, but its prevalence on social media platforms, such as Twitter (now X) remains unclear. Social media bots are known to...
| Autors principals: | , , , , |
|---|---|
| Format: | Article |
| Idioma: | English |
| Publicat: |
Wiley
2024-04-01
|
| Col·lecció: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Matèries: | |
| Accés en línia: | https://www.ahajournals.org/doi/10.1161/JAHA.123.032678 |